Oppenheimer Upgrades DiaMedica Therapeutics Inc. (DMAC) to Outperform as clinical hold removed
Tweet Send to a Friend
(Updated - June 22, 2023 8:41 AM EDT)
Oppenheimer analyst Francois Brisebois upgraded DiaMedica Therapeutics Inc. (NASDAQ: DMAC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Francois Brisebois upgraded DiaMedica Therapeutics Inc. (NASDAQ: DMAC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
